48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis

      research-article
      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , , MD and PhD 10 , 11 , 12 , 13 , 13 , 14 , 15 , 16 , 16 , 17 , 16 , 18 , 19 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , , 6 , 1 , A Global Obstetrics Network (GONet) Collaboration
      The BMJ
      BMJ Publishing Group Ltd.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective To determine the risks of stillbirth and neonatal complications by gestational age in uncomplicated monochorionic and dichorionic twin pregnancies.

          Design Systematic review and meta-analysis.

          Data sources Medline, Embase, and Cochrane databases (until December 2015).

          Review methods Databases were searched without language restrictions for studies of women with uncomplicated twin pregnancies that reported rates of stillbirth and neonatal outcomes at various gestational ages. Pregnancies with unclear chorionicity, monoamnionicity, and twin to twin transfusion syndrome were excluded. Meta-analyses of observational studies and cohorts nested within randomised studies were undertaken. Prospective risk of stillbirth was computed for each study at a given week of gestation and compared with the risk of neonatal death among deliveries in the same week. Gestational age specific differences in risk were estimated for stillbirths and neonatal deaths in monochorionic and dichorionic twin pregnancies after 34 weeks’ gestation.

          Results 32 studies (29 685 dichorionic, 5486 monochorionic pregnancies) were included. In dichorionic twin pregnancies beyond 34 weeks (15 studies, 17 830 pregnancies), the prospective weekly risk of stillbirths from expectant management and the risk of neonatal death from delivery were balanced at 37 weeks’ gestation (risk difference 1.2/1000, 95% confidence interval −1.3 to 3.6; I 2=0%). Delay in delivery by a week (to 38 weeks) led to an additional 8.8 perinatal deaths per 1000 pregnancies (95% confidence interval 3.6 to 14.0/1000; I 2=0%) compared with the previous week. In monochorionic pregnancies beyond 34 weeks (13 studies, 2149 pregnancies), there was a trend towards an increase in stillbirths compared with neonatal deaths after 36 weeks, with an additional 2.5 per 1000 perinatal deaths, which was not significant (−12.4 to 17.4/1000; I 2=0%). The rates of neonatal morbidity showed a consistent reduction with increasing gestational age in monochorionic and dichorionic pregnancies, and admission to the neonatal intensive care unit was the commonest neonatal complication. The actual risk of stillbirth near term might be higher than reported estimates because of the policy of planned delivery in twin pregnancies.

          Conclusions To minimise perinatal deaths, in uncomplicated dichorionic twin pregnancies delivery should be considered at 37 weeks’ gestation; in monochorionic pregnancies delivery should be considered at 36 weeks.

          Systematic review registration PROSPERO CRD42014007538.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: not found
          • Article: not found

          PEDIATRICS

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity

            Background Health care planning for chronic pelvic pain (CPP), an important cause of morbidity amongst women is hampered due to lack of clear collated summaries of its basic epidemiological data. We systematically reviewed worldwide literature on the prevalence of different types of CPP to assess the geographical distribution of data, and to explore sources of variation in its estimates. Methods We identified data available from Medline (1966 to 2004), Embase (1980 to 2004), PsycINFO (1887 to 2003), LILACS (1982 to 2004), Science Citation index, CINAHL (January 1980 to 2004) and hand searching of reference lists. Two reviewers extracted data independently, using a piloted form, on participants' characteristics, study quality and rates of CPP. We considered a study to be of high quality (valid) if had at least three of the following features: prospective design, validated measurement tool, adequate sampling method, sample size estimation and response rate >80%. We performed both univariate and multivariate meta-regression analysis to explore heterogeneity of results across studies. Results There were 178 studies (459975 participants) in 148 articles. Of these, 106 studies were (124259 participants) on dysmenorrhoea, 54 (35973 participants) on dyspareunia and 18 (301756 participants) on noncyclical pain. There were only 19/95 (20%) less developed and 1/45 (2.2%) least developed countries with relevant data in contrast to 22/43 (51.2%) developed countries. Meta-regression analysis showed that rates of pain varied according to study quality features. There were 40 (22.5%) high quality studies with representative samples. Amongst them, the rate of dysmenorrhoea was 16.8 to 81%, that of dyspareunia was 8 to 21.8%, and that for noncyclical pain was 2.1 to 24%. Conclusion There were few valid population based estimates of disease burden due to CPP from less developed countries. The variation in rates of CPP worldwide was due to variable study quality. Where valid data were available, a high disease burden of all types of pelvic pain was found.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Stillbirths: recall to action in high-income countries.

              Variation in stillbirth rates across high-income countries and large equity gaps within high-income countries persist. If all high-income countries achieved stillbirth rates equal to the best performing countries, 19,439 late gestation (28 weeks or more) stillbirths could have been avoided in 2015. The proportion of unexplained stillbirths is high and can be addressed through improvements in data collection, investigation, and classification, and with a better understanding of causal pathways. Substandard care contributes to 20-30% of all stillbirths and the contribution is even higher for late gestation intrapartum stillbirths. National perinatal mortality audit programmes need to be implemented in all high-income countries. The need to reduce stigma and fatalism related to stillbirth and to improve bereavement care are also clear, persisting priorities for action. In high-income countries, a woman living under adverse socioeconomic circumstances has twice the risk of having a stillborn child when compared to her more advantaged counterparts. Programmes at community and country level need to improve health in disadvantaged families to address these inequities.
                Bookmark

                Author and article information

                Contributors
                Role: clinical research fellow
                Role: postdoctoral research fellow
                Role: biostatistician
                Role: consultant obstetrician
                Role: senior scientist
                Role: professor of obstetrics and gynaecology
                Role: associate professor
                Role: in obstetrics and gynaecology
                Role: assistant professor in obstetrics and gynaecology
                Role: gynaecologist
                Role: MD in obstetrics and gynaecology
                Role: professor of maternal and fetal health
                Role: professor of obstetrics and gynaecology and paediatrics
                Role: associate director of research
                Role: director of research and education, professor emeritus of obstetrics and gynaecology
                Role: associate director
                Role: professor of obstetrics and gynaecology
                Role: professor of obstetrics and gynaecology
                Role: senior resident
                Role: specialist in obstetrics and gynaecology
                Role: professor of obstetrics and gynaecology
                Role: professor of obstetrics and gynaecology
                Role: principal investigatorRole: professor of obstetrics and gynaecology
                Role: research professor of biostatistics and epidemiology
                Role: consultant obstetrician and gynaecologist, senior lecturer in maternal fetal medicine
                Role: assistant professor
                Role: MD in obstetrics and gynaecology
                Role: chief of obstetrics and associate professor
                Role: professor of obstetrics and gynaecology
                Role: professor and Maas chair for reproductive sciences
                Role: senior lecturer
                Role: data analyst
                Role: professor of obstetrics and gynaecology
                Role: senior lecturer, head of clinical biostatistics unit, director of clinical epidemiology research area
                Role: professor and director of fetal medicine
                Role: professor of maternal and perinatal health
                Journal
                BMJ
                BMJ
                bmj
                The BMJ
                BMJ Publishing Group Ltd.
                0959-8138
                1756-1833
                2016
                6 September 2016
                : 354
                : i4353
                Affiliations
                [1 ]Women’s Health Research Unit, Barts and the London School of Medicine and Dentistry, Queen Mary University of London E1 2AB, UK
                [2 ]Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands
                [3 ]Department of Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, Netherlands
                [4 ]Stanford Prevention Research Center, Stanford University, Palo Alto, Stanford, CA 94305, USA
                [5 ]Clinical Biostatistics Unit, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
                [6 ]Fetal Medicine Unit, St George’s Healthcare NHS Trust, London SW17 0QT, UK
                [7 ]Evaluative Clinical Sciences, Women and Babies Research Program, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada
                [8 ]Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC V6Z 2K5, Canada
                [9 ]Department of Newborn and Developmental Paediatrics, Women and Babies Research Program, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada
                [10 ]Department of Gynaecology and Obstetrics, Diakonessenhuis, 3582 KE Utrecht, Netherlands
                [11 ]Department of Obstetrics-Gynaecology, University Hospitals, 3000 Leuven, Belgium
                [12 ]Department of Development and Regeneration: Pregnancy, Fetus and Neonate, KU Leuven, Belgium
                [13 ]Department of Obstetrics and Gynaecology, Academic Medical Centre, 1105 AZ Amsterdam, Netherlands
                [14 ]University of Edinburgh MRC Centre for Reproductive Health, Queen’s Medical Research Institute, Edinburgh EH16 4TY, UK
                [15 ]Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MS, USA
                [16 ]Obstetrix Collaborative Research Network, Center for Research, Education and Quality, Mednax National Medical Group, FL 33323, USA
                [17 ]University of California Irvine, Irvine, CA 92697, USA
                [18 ]Maternal-Fetal Medicine Unit, Instituto Valenciano de Infertilidad, University of Valencia, Spain
                [19 ]Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Valencia, Jefe Servicio Obstetricia Hospital U P La FE, Torre F, Valencia, Espana
                [20 ]Department of Obstetrics, University Hospital La Fe, Valencia, 46026 València, Spain
                [21 ]Centre of Fetal Medicine, Department of Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
                [22 ]Department of Obstetrics and Gynaecology, Medical University of Vienna, 1090 Wien, Austria
                [23 ]Department of Obstetrics and Gynaecology, American University of Beirut Medical Centre, Riad El Solh, Beirut 1107 2020, Lebanon
                [24 ]The Egyptian IVF Centre, Maadi and Department of Obstetrics and Gynaecology, Faculty of Medicine, Cairo University, Oula, Giza, Egypt
                [25 ]Department of Obstetrics and Gynecology, Women and Infants Hospital, Brown University Women and Infants Hospital, Providence, RI 02905, USA
                [26 ]Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin, Republic of Ireland
                [27 ]Department of Maternal Fetal Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Osaka 594-1101, Japan
                [28 ]Department of Obstetrics and Gynecology, University of Milano-Bicocca, 20126 Milan, Italy
                [29 ]Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
                [30 ]Robinson Research Institute, and Discipline of Obstetrics and Gynaecology, University of Adelaide, North Adelaide SA 5006, Australia
                [31 ]Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC 29403, USA
                [32 ]University of Aberdeen, Dugald Baird Centre for Research on Women’s Health, Aberdeen Maternity Hospital, Aberdeen AB25 2ZL, UK
                [33 ]Department of Obstetrics and Gynecology, Alberta Health Services, Calgary, AB T2N 2T9, Canada
                [34 ]Australian Research Centre for Health of Women and Babies, Robinson Institute, University of Adelaide, North Adelaide, SA 5006, Australia
                [35 ]Clinical Biostatistics Unit, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain
                [36 ]CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
                Author notes
                Correspondence to: J Zamora javier.zamora@ 123456hrc.es
                Article
                chef027508
                10.1136/bmj.i4353
                5013231
                27599496
                1cec9d07-d003-4cf3-b9a2-b0deaeaa620f
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/.

                History
                : 06 August 2016
                Categories
                Research

                Medicine
                Medicine

                Comments

                Comment on this article